Trending Now
Drug Discovery and Development
Aureka Biotechnologies raises US$100 million to build a biological world model for drug discovery
Aureka Biotechnologies has closed financing of US$100 million.
The company will direct proceeds primarily toward research and large-scale training of its next generation of biological...
Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine
Oncoinvent, a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose,...
US FDA approves Takeda’s Orzeyful (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
The US Food and Drug Administration (FDA) has approved Takeda’s Orzeyful (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy...
Lilly’s olomorasib receives US FDA breakthrough therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Eli Lilly and Company’s olomorasib as a monotherapy for the treatment...
Mediar Therapeutics enters into a collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases
Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, has entered into a collaboration and option agreement with...
ECOG-ACRIN and NRG oncology study demonstrates multimodal AI approach to predict late distant recurrence risk in HR+ early breast cancer
Caris Life Sciences, a leading TechBio company, has published a study in Cancer Research Communications demonstrating the ability of a multimodal, multitask deep learning model to...
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro, a global therapy-enabling company offering precise navigation and delivery...
BridgeBio announces FDA acceptance of NDA for encaleret for ADH1
BridgeBio Pharma, Inc., a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, has announced the FDA has accepted for filing its...
Clinical Trials Insight
Novo Nordisk provides update on a phase 3 trial in people with ASCVD, CKD and inflammation
Novo Nordiskhas announced headline results from the cardiovascular outcomes from a phase 3 trial.
While ziltivekimab demonstrated target engagement and inhibition of the IL-6 pathway,...
Kodiak Sciences completes enrolment in first pivotal cohort in the phase 3 trial of KSI-101 for macular oedema secondary to inflammation and reaffirms topline...
Kodiak Sciences Inc. has completed enrolment of the first 300-patient cohort in its clinical trial, supporting pivotal analysis of the KSI-101 phase 3 programme...
Ractigen Therapeutics announces completion of enrolment and first dosing in phase 2 clinical trial of RAG-17 for SOD1-ALS
Ractigen Therapeutics, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics, has completed patient enrolment and initial dosing across all cohorts in its phase 2...
BioVie announces topline results of phase 2 trial of bezisterim in early Parkinson’s disease
BioVie Inc., a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, has announced results from the phase 2 trial evaluating its...
Vivani Medical announces successful dosing of all participants in a phase 1 trial evaluating NPM-139, a miniature, ultra long-acting semaglutide implant for chronic weight...
Vivani Medical, Inc., has announced full enrolment and successful initial dosing of all participants in its phase 1 trial for NPM-139, a miniature, subdermal...
VIDEOS
Pharma in Healthcare
Roche expands cyclospora testing portfolio to support US public health response
As a cyclospora outbreak continues to spread throughout the United States, Roche, in collaboration with subsidiary TIB MOLBIOL, has made available two new flexible and...
Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
The European Commission (EC) has approved an extension of the indication for Sanofi’s MenQuadfi (meningococcal Group A, C, W and Y conjugate vaccine) to...
Nipro Corporation receives FDA 510(k) clearance for Elisio-HX, introducing HDs to the United States
Nipro Corporation has been granted 510(k) clearance for the Elisio-HX dialyser by the United States Food and Drug Administration (FDA).
The clearance enables the introduction...
European Commission authorises Pfizer and BioNTech XFG-adapted COVID-19 vaccine in the European Union
Pfizer and BioNTech SE have been granted marketing authorisation by the European Commission (EC) for the companies’ 2026-2027 COVID-19 vaccine formula, targeting the XFG...
IBSA foundation fellowships shatter records with unprecedented global reach and opens 2026 call
IBSA Foundation (Institut Biochimique SA) for scientific research, recently announced a record-shattering year for its prestigious fellowship programme, drawing an unprecedented 398 applications from 64 countries....
Technology and Automation
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers
Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line, designed to offer broader access to optimised workflows for PCR applications such as sequencing,...
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities
PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...
Ledger Run first to bring AI-powered automation to clinical trial payments
Ledger Run, a leader in clinical trial financial management solutions, has announced significant upgrades to its ClinRun platform, including intelligent automation and expanded flexibility to accelerate...
Trelleborg strengthens quality compliance with ISO certification in Costa Rica
Trelleborg Medical Solutions’ manufacturing site in Costa Rica has earned ISO 13485:2016 certification, helping ensure product consistency and compliance.
ISO 13485:2016 is a process-focused quality framework...
Liebherr expands UK lab portfolio
Commercial refrigeration specialist Liebherr has introduced seven high performance countertop and fully integrated under bench models in their UK lab and healthcare range.
These include...
Pharma packaging and logistics
RenovoRx announces first commercial clinical use of RenovoCath in sarcoma patient treatment, marking expansion of targeted drug-delivery device to other solid tumours
RenovoRx, a life sciences company developing innovative targeted oncology therapies and commercialising RenovoCath, a patented, FDA-cleared drug-delivery device, has announced the first commercial clinical use...
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro, a global therapy-enabling company offering precise navigation and delivery...
Liraglutide combination products incorporating Stevanato Group’s Alina pen injector received marketing authorisations in multiple European countries
Stevanato Group SpA, a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, has...
Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC
Octapharma, the largest privately owned and independent plasma fractionator in the world, has formally announced plans to establish its first-ever United States-based manufacturing and production site at the Palmetto Research Park in Rock Hill, South Carolina.
The $1.5 billion project is expected to bring 1,500...
Nipro Corporation receives FDA 510(k) clearance for Elisio-HX, introducing HDs to the United States
Nipro Corporation has been granted 510(k) clearance for the Elisio-HX dialyser by the United States Food and Drug Administration (FDA).
The clearance enables the introduction...
Events and conferences
Sustainability, AI and resilience take centre stage at CPHI Milan 2026
This year’s CPHI conference in Europe will introduce a new sustainability summit, as well as exhibitor zones focusing on AI, contamination control and logistics.
CPHI...
ELRIG unveils keynote speakers for Drug Discovery 2026
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the keynote speaker programme for Drug Discovery 2026.
This year’s event...
Ilmac Lausanne 2026 puts the laboratory of the future, AI and biotools centre stage
Ilmac Lausanne 2026 is expected to attract around 200 exhibitors and 3,500 trade visitors.
At its core will be a conference programme featuring over...
Drug Delivery and Formulation Summit (DDF)
14-15 September 2026
Boston, USA
The 16th American Drug Delivery & Formulation will once again bring together an exceptional line-up of the industry's best speakers, with...
PharmSci 360
25-28 October New Orleans, USA
Thousands of scientists from around the world will converge in New Orleans from 25 to 28 October to discuss cutting-edge...
Funding and Finance
Aureka Biotechnologies raises US$100 million to build a biological world model for drug discovery
Aureka Biotechnologies has closed financing of US$100 million.
The company will direct proceeds primarily toward research and large-scale training of its next generation of biological...
Schrödinger announces strategic collaboration and software agreement with Bristol Myers Squibb to deploy Bunsen, an AI co-scientist
Schrödinger, Inc. has entered a strategic agreement with Bristol Myers Squibb (BMS) to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organisation.
Building on a...
Mediar Therapeutics enters into a collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases
Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, has entered into a collaboration and option agreement with...
Verified Clinical Trials partners with WindRose Health Investors to accelerate growth and welcomes Howard Miller as Chief Executive Officer
Verified Clinical Trials, the global leader in clinical trial subject registry solutions, has entered a new partnership with WindRose Health Investors to begin an...
MiMedx to acquire Sanara MedTech
MiMedx Group, Inc. and Sanara MedTech Inc. have entered into a definitive merger agreement under which MiMedx will acquire all of the outstanding shares...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
MOST POPULAR POSTS
© 2026 Pharma Press Publishing.